Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes.
Saved in:
| Title: | Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. |
|---|---|
| Authors: | Purvis GSD; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Collino M; Department of Drug Science and Technology, University of Turin, Turin, Italy., Loiola RA; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Baragetti A; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy., Chiazza F; Department of Drug Science and Technology, University of Turin, Turin, Italy., Brovelli M; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy., Sheikh MH; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Collotta D; Department of Drug Science and Technology, University of Turin, Turin, Italy., Cento A; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Mastrocola R; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy., Aragno M; Department of Molecular Biotechnology and Sciences for the Health, University of Turin, Turin, Italy., Cutrin JC; Department of Molecular Biotechnology and Sciences for the Health, University of Turin, Turin, Italy., Reutelingsperger C; Department of Biochemistry, Cardiovascular Research Institute, Maastricht University, Maastricht, Netherlands., Grigore L; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy.; IRCCS Multimedica, Lombardy, Italy., Catapano AL; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy., Yaqoob MM; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Norata GD; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy., Solito E; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli 'Federico II', Naples, Italy., Thiemermann C; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2019 Mar 27; Vol. 10, pp. 571. Date of Electronic Publication: 2019 Mar 27 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30972066 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Purvis+GSD%22">Purvis GSD</searchLink>; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Collino+M%22">Collino M</searchLink>; Department of Drug Science and Technology, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Loiola+RA%22">Loiola RA</searchLink>; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Baragetti+A%22">Baragetti A</searchLink>; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Chiazza+F%22">Chiazza F</searchLink>; Department of Drug Science and Technology, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Brovelli+M%22">Brovelli M</searchLink>; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy.<br /><searchLink fieldCode="AU" term="%22Sheikh+MH%22">Sheikh MH</searchLink>; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Collotta+D%22">Collotta D</searchLink>; Department of Drug Science and Technology, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Cento+A%22">Cento A</searchLink>; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Mastrocola+R%22">Mastrocola R</searchLink>; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Aragno+M%22">Aragno M</searchLink>; Department of Molecular Biotechnology and Sciences for the Health, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Cutrin+JC%22">Cutrin JC</searchLink>; Department of Molecular Biotechnology and Sciences for the Health, University of Turin, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Reutelingsperger+C%22">Reutelingsperger C</searchLink>; Department of Biochemistry, Cardiovascular Research Institute, Maastricht University, Maastricht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Grigore+L%22">Grigore L</searchLink>; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy.; IRCCS Multimedica, Lombardy, Italy.<br /><searchLink fieldCode="AU" term="%22Catapano+AL%22">Catapano AL</searchLink>; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Yaqoob+MM%22">Yaqoob MM</searchLink>; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Norata+GD%22">Norata GD</searchLink>; Department of Pharmacological and Biomolecular Sciences, Università Degli Studi di Milano, Milan, Italy.; Centro SISA per lo studio del'Aterosclerosi, Bassini Hospital, Lombardy, Italy.<br /><searchLink fieldCode="AU" term="%22Solito+E%22">Solito E</searchLink>; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli 'Federico II', Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Thiemermann+C%22">Thiemermann C</searchLink>; Department of Translational Medicine and Therapeutics, Bart's and The London School of Medicine and Dentistry, The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2019 Mar 27; Vol. 10, pp. 571. <i>Date of Electronic Publication: </i>2019 Mar 27 (<i>Print Publication: </i>2019). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30972066 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2019.00571 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 571 Titles: – TitleFull: Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Purvis GSD – PersonEntity: Name: NameFull: Collino M – PersonEntity: Name: NameFull: Loiola RA – PersonEntity: Name: NameFull: Baragetti A – PersonEntity: Name: NameFull: Chiazza F – PersonEntity: Name: NameFull: Brovelli M – PersonEntity: Name: NameFull: Sheikh MH – PersonEntity: Name: NameFull: Collotta D – PersonEntity: Name: NameFull: Cento A – PersonEntity: Name: NameFull: Mastrocola R – PersonEntity: Name: NameFull: Aragno M – PersonEntity: Name: NameFull: Cutrin JC – PersonEntity: Name: NameFull: Reutelingsperger C – PersonEntity: Name: NameFull: Grigore L – PersonEntity: Name: NameFull: Catapano AL – PersonEntity: Name: NameFull: Yaqoob MM – PersonEntity: Name: NameFull: Norata GD – PersonEntity: Name: NameFull: Solito E – PersonEntity: Name: NameFull: Thiemermann C IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 03 Text: 2019 Mar 27 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 10 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |